Mirabegron 67877-0890
Product NDC
67877-0890- Manufacturer
- Ascend Laboratories, Llc
- Dosage Form
- For Suspension, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 15, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219323
Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 8 mg/mL |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(1)
1 POUCH in 1 CARTON (67877-890-88) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE